ArticleJournal of advanced research2026
Urinary Cell-Free DNA detection platform for bacterial cystitis diagnosis via spot-based machine learning.
Article in Journal of advanced research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- More than an infection: the ecological puzzle of recurrent urinary tract infections.Frontiers in cellular and infection microbiology · 2026Review
- PANoptosis: potential new targets and therapeutic prospects in digestive diseases.Apoptosis : an international journal on programmed cell death · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionBacterial cystitis is a prevalent infectious condition that is primarily caused by uropathogenic Escherichia coli (E. coli). The rapid and precise identification of this pathogen is crucial for guiding timely and effective clinical intervention. Urinary cell-free DNA (cfDNA) has emerged as a promising biomarker for cystitis, yet its complex origins from both inflammatory and infectious processes pose challenges in distinguishing bacterial from non-bacterial etiologies.
objectivesHere, we developed an innovative image-based, machine learning-assisted fluorescent detection system for simultaneous quantitative and qualitative analysis of urinary cfDNA to diagnose bacterial cystitis.
methodsThe detection system utilizes polyethyleneimine (PEI)-functionalized glass slides for efficient cfDNA enrichment, followed by fluorescence imaging with propidium iodide labeling. The performance of the detection system was rigorously validated using a bacterial cystitis mouse model and human urine specimens.
resultsThis platform enables rapid quantification of cfDNA within 20 min, with a calibration range of 31.25-4000 ng mL
conclusionRequiring no urine pretreatment, this rapid, on-site platform represents a transformative advance in point-of-care testing (POCT) for bacterial cystitis, with potential applications for digital biomarker detection in diverse inflammatory and infectious diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.